CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy-Reference-Cited by-同舟云学术

CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy

Published:2016-09-08 Issue:2 Volume:180 Page:292-296
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bras Anne E.¹,Beishuizen Auke²,Langerak Anton W.¹,Jongen-Lavrencic Mojca³,te Marvelde Jeroen G.¹,van den Heuvel-Eibrink Marry M.²,Zwaan C. Michel²,van Dongen Jacques J. M.¹,van der Velden Vincent H. J.¹

Affiliation:

1. Laboratory Medical Immunology; Department of Immunology; Erasmus MC; University Medical Center Rotterdam; Rotterdam The Netherlands

2. Department of Paediatric Oncology/Haematology; Erasmus MC - Sophia Children's Hospital; University Medical Centre Rotterdam; Rotterdam The Netherlands

3. Department of Haematology; Erasmus MC; University Medical Centre Rotterdam; Rotterdam The Netherlands

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14310/fullpdf

Reference11 articles.

1. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes;Dongen;Leukemia,2012

2. Monoclonal antibodies targeting CD38 in hematological malignancies and beyond;Donk;Immunological Reviews,2016

3. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia;Durig;Leukemia,2002

4. Acute myeloid leukemia: leukemia stem cells write a prognostic signature;Gudgin;Stem Cell Research & Therapy,2011

5. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia;Hsi;British Journal of Haematology,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults;Journal of the National Comprehensive Cancer Network;2024-07

2. Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia;Haematologica;2024-05-10

3. Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study;Annals of Hematology;2024-04-25

4. The surprising relationship between CD38 and lipid metabolic in acute myeloid leukemia;2024-01-24

5. CD38 as a therapeutic target in pediatric Burkitt’s Lymphoma: insights from a comparative approach (Running title: Targeting CD38 in pediatric Burkitt's Lymphoma);2024-01-19